Amarin Corp Plc (AMRN)

[gozips]

The preponderance of evidence was clearly in favor of plaintiffs with respect to FDA regulatory status, medical practice and commercial success. The research, prior art, was validated as "obvious" by Du's use of hindsight and shifting the burden of proof on plaintiffs. Remember, it was Du that made the leap that treatment for TG>500 was equal to treatment for TG<500!